BioLight Life Sciences (XTAE:BOLT) ROE % Adjusted to Book Value : 7.96% (As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences ROE % Adjusted to Book Value?

BioLight Life Sciences's ROE % for the quarter that ended in Jun. 2024 was 5.49%. BioLight Life Sciences's PB Ratio for the quarter that ended in Jun. 2024 was 0.69. BioLight Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 7.96%.

BioLight Life Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for BioLight Life Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences ROE % Adjusted to Book Value Chart

BioLight Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-30.29

-36.03

0.74

-24.18

-77.46

BioLight Life Sciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															10.91	-60.96	-	-58.00	7.96

Competitive Comparison of BioLight Life Sciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, BioLight Life Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLight Life Sciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's ROE % Adjusted to Book Value falls into.

BioLight Life Sciences ROE % Adjusted to Book Value Calculation

BioLight Life Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-62.74%	/	0.81
	=	-77.46%

BioLight Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.49%	/	0.69
	=	7.96%

BioLight Life Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLight Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Aba Hillel Silver 12, 11 floor, Ramat Gan, ISR, 5250606

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.